Botanical species · safety record

Chrysophyllum cainito

The EFSA Compendium of Botanicals holds 3 constituent measurements for Chrysophyllum cainito. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Chrysophyllum cainito L.

3Constituent measurements
0Safety records
2Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Alkaloids2
  • Lectins1

Plant parts

  • Fruit unspecified2
  • Leaves1

Preparations

  • Solvent extraction2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsFruit unspecifiedSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
AlkaloidsLeavesSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
LectinsFruit unspecified145480 International Unit/gramAgglutination tests (Agg.)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Wongkham, Sopit., Boonsiri, Patcharee., Trisonthi, Chusri., Simasathiansophon, Sonthaya., Wongkham, Chaisiri., Atisook, Kanit. Studies on lectins from thai plants. Journal of the Science Society of Thailand, 1995, p. 27-36.
  2. Coe, F.G., Parikh, D.M., Johnson, C.A., Anderson, G.J. The good and the bad: Alkaloid screening and brineshrimp bioassays of aqueous extracts of 31 medicinal plants of eastern Nicaragua. Pharmaceutical Biology, 2012, vol. 50, no. 3, p. 384-392. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue